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Background.– Long-term management of cervical dystonia (CD) involves
repeated botulinum toxin injections at around 3-month intervals. Many patients
and physicians may prefer shorter intervals but it is assumed that these might
increase the risk of adverse events (AEs) and neutralizing antibody formation.
We analyzed the clinical need and safety of flexible injection intervals with
Incobotulinumtoxin A (Xeomin1, NT 201), a purified botulinum toxin type A
free from accessory (complexing) proteins.
Methods.– Post-hoc analysis was carried out using data from a randomized,
double-blind, placebo-controlled phase 3 study with a randomized, double-
blind extension period. Subjects with CD (pretreated or botulinum toxin
treatment naïve) could receive  6 Incobotulinumtoxin A treatments with fixed
doses (120 or 240 U) but flexible intervals ( 6 weeks). Reinjection occurred
when subjects and physicians agreed on the need and subjects had a Toronto
Western Spasmodic Torticollis Rating Scale Total score of  20. Standard
safety assessments were performed throughout.
Results.– Two hundred and fourteen subjects entered the extension period (120
U dose group, n = 103; 240U dose group, n = 111). In total, 821
incoboyulinumtoxin A injections were included in this analysis: 369
(44,9%) given at 6–11 week intervals and 452 (55,1%) at 12–20 weeks
intervals. Frequency and severity of AEs were similar, irrespective of injection
intervals (< 12 weeks versus  12 weeks), with no cumulative effects of
repeated treatment. As would be expected in CD, the most frequent AEs were
dysphagia, muscle weakness, neck pain, and injection-site pain.
Discussion.– Incobotulinumtoxin A (Xeomin1), injected at flexible intervals
according to subjects’ clinical needs, is effective and well tolerated in the long-
term management of CD.
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Introduction.– The equinus foot deformity is common in hemiparetic patients.
Although widely used, the reproducibility of goniometric measurement of ankle
dorsiflexion is little studied and variable. The objective was to evaluate the intra/
inter rater-reliability of this measure, and to evaluate a new method of
goniometric measurement of ankle dorsiflexion in hemiparetic patients.
Methods.– Prospective, monocentric study; all hemiparetic patients due to a
recent brain injury, hospitalized during the study period were included.
Goniometric measurements of ankle dorsiflexion were performed on both healthy
and hemiplegic sides, by four judges, and repeated a week later. Landmarks were
either free (corresponding to the evaluators’ usual practice) or imposed. The
conventional method evaluated the equinus on the hemiparetic side. The S. Index
was defined as the difference between the dorsiflexion on the hemiplegic side and
on the healthy side. Intra and inter-rater reliabilities were computed for both
methods (conventional and S) with an intraclass correlation coefficient (ICC).
Results.– Thirty-four patients were included (88% stroke patients). Intra-rater
ICC was good for the classical method (0.72 to 0.78) and ranged from mediocre
to moderate for the S. Index (0.43 to 0.70) with imposed landmarks; it ranged
from very bad to moderate (0.22 to 0.66) for the S. Index with free landmarks.
Inter-rater ICC was moderate (0.62) for the classical method (free or imposed
landmarks) at day 1 and day 7; it was mediocre with imposed landmarks at day 1
and day 7 (0.44 and 0.56) and moderate at day 1 and day 7 (0.52 and 0.56) for the S.
index.
Discussion.– This study confirmed that the intra and inter-rater reliability of
goniometric measurements of equinus were not satisfying, whatever the method.
Therefore, the search for a method that has better metrological qualities is
necessary.
Intra-rater reliability was better with conventional method and free landmarks;
however, one coefficient was correct for one judge with the new method, which
has to be improved.
Inter-rater reliability didn’t seem to be better for the S Index.
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Introduction.– In chronic hemiparesis, active ankle dorsiflexion deficit at swing
phase is associated with contracture and cocontraction in triceps surae and paresis
of tibialis anterior [1]. We aimed to analyze the role of triceps surae spasticity vs
cocontraction and tibialis anterior paresis in the hémiparetic gait disorder.
Methods.– Nineteen patients with chronic hemiparesis (45  16 years)
participated. The spasticity grade and angle (XV1-XV3) of triceps surae (knee
extended) and the angle of weakness (XV1-A) of dorsiflexion were measured using
the step-wise assessment of spastic paresis, including the Tardieu scale [2,3]. Each
subject performed a 10-meter barefoot walking test (seated start and arrival) at
preferred and maximal speed. Spatial-temporal parameters were quantified:
speed, step length and cadence. We explored correlations between spasticity and
weakness parameters at the ankle and gait spatial-temporal parameters.
Results.– At preferred speed: speed, 0.69 0.25 m/s; step length, 0.51 0.12 m;
cadence, 1.33 0.31step/s. At fast speed: speed, 1.08 0.40 m/s; step length,
0.55 0.15 m; cadence, 1.91  0.39step/s. In the paretic ankle: triceps surae
spasticity grade, 2.2  0.8; spasticity angle, 13.7 6.58; dorsiflexion angle of
weakness, 13.2 9.38.
At preferred speed, the angle of weakness was negatively correlated with speed
(r = –0.48, P = 0.039), step length (r = –0.55, P = 0.014), and at fast speed, with
speed (r = –0.56, P = 0.012), step length (r = –0.57, P = 0.010) and cadence
(r = –0.47, P = 0.040).
Conclusions.– In chronic hemiparesis, ambulation (at preferred and fast speed),
is correlated at the ankle with the combination of tibialis anterior paresis and
triceps surae cocontraction rather than with triceps surae spasticity.
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